| Literature DB >> 35705642 |
Binna Lv1, Lele Fan1, Shidong Li1, Manhong Sun2.
Abstract
Clonostachys chloroleuca 67-1 (formerly C. rosea 67-1) is a promising mycoparasite with great potential for controlling various plant fungal diseases. The mitogen-activated protein kinase (MAPK)-encoding gene Crmapk is of great importance to the mycoparasitism and biocontrol activities of C. chloroleuca. To investigate the molecular mechanisms underlying the role of Crmapk in mycoparasitism, a high-quality yeast two hybrid (Y2H) library of C. chloroleuca 67-1 was constructed, and proteins interacting with Crmapk were characterised. The library contained 1.6 × 107 independent clones with a recombination rate of 96%, and most inserted fragments were > 1 kb. The pGBKT7-Crmapk bait vector with no self-activation or toxicity to yeast cells was used to screen interacting proteins from the Y2H library, resulting in 60 candidates, many linked to metabolism, cellular processes and signal transduction. Combined bioinformatics and transcriptome analyses of C. chloroleuca 67-1 and ΔCrmapk mutant mycoparasitising Sclerotinia sclerotiorum sclerotia, 41 differentially expressed genes were identified, which might be the targets of the Fus3/Kss1-MAPK pathway. The results provide a profile of potential protein interactions associated with MAPK enzymes in mycoparasites, and are of great significance for understanding the mechanisms of Crmapk regulating C. chloroleuca mycoparasitism.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35705642 PMCID: PMC9200739 DOI: 10.1038/s41598-022-13899-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Figure 1Analysis of the quality of the primary C. chloroleuca 67-1 library. (a) Determination of storage capacity. (b) Determination of recombination rate using primers pGADT7-F/R. (c) Determination of the mean length of inserted fragments from fungal colonies randomly selected by PCR amplification with primers pGADT7-F/R. M DNA 2000 marker, bp base pairs.
Figure 2Construction of pGBKT7-Crmapk bait vector in C. chloroleuca 67-1. (a) Domain structure of Crmapk as annotated by SMART (http://smart.embl.de/). (b) Verification of the recombinant pGBKT7-Crmapk bait vector. M, DNA 5000 markers; Lanes 1–2, verification of the pGBKT7-Crmapk bait vector using vector primers T7/3′BD; Lanes 3–4, verification of the bait vector using target gene primers Crmapk-F/Crmapk-R. (c) Self-activation tests of the pGBKT7-Crmapk bait vector. The bait and empty vector pGADT7 were transformed into the Y2H Gold strain and cultured on SD/-Trp/X medium. pGBKT7-p53 and pGADT7-T were used together as a positive control, while pGBKT7-Lam and pGADT7-T served as a negative control.
Figure 3Screening and identification of putative interacting proteins in C. chloroleuca 67-1 via Y2H. (a) Positive clones screened on DDO/X/A plates. (b) Positive clones screened on QDO/X/A plates. “+” represents the positive control; “−” represents the negative control. (c) Interaction validation for individual hits. pGBKT7-53 and pGADT7-T plasmids were co-transformed into Y2H Gold cells as a positive control, while the pGBKT7-Lam and pGADT7-T served as a negative control. Three replicates were carried out for each treatment, and three plates were presented in the results.
Figure 4Gene Ontology functional classification of Crmapk-interacting proteins in C. chloroleuca 67-1. (a) Classification of interacting proteins based on biological process. (b) Classification of interacting proteins based on molecular function. (c) Subcellular localisation of interacting proteins. Blast2GO and WoLF SPORT Software were used for GO functional classification analysis.
Genes interacting with Crmapk that are differentially expressed in the transcriptome of C. chloroleuca 67-1 parasitising S. sclerotiorum.
| Gene ID | Log2 FC (B8/A8) | Log2 FC (B24/A24) | Log2 FC (B48/A48) | Annotation |
|---|---|---|---|---|
| 0.31 | 1.84 | 1.10 | Acetyl-CoA carboxylase | |
| 0.55 | 0.25 | 1.04 | 6-Phosphofructokinase subunit alpha | |
| − 0.66 | 0.90 | 3.52 | DNA polymerase eta subunit | |
| 2.33 | 1.60 | 2.67 | Glucoamylase | |
| − 1.19 | − 1.52 | − 2.39 | NADH kinase pos5 | |
| − 0.38 | 0.41 | 1.08 | Methionine aminopeptidase | |
| − 0.14 | − 0.38 | 1.87 | ||
| 1.38 | 1.42 | 1.52 | Alpha-mannosidase | |
| 1.62 | 1.36 | 2.26 | Protein transport protein sec-13 | |
| − 2.18 | − 1.40 | − 0.51 | Hypothetical protein | |
| 1.79 | 0.80 | − 0.39 | SH3 domain-containing protein | |
| 1.22 | 0.53 | 0.31 | Glutamate decarboxylase | |
| 1.78 | 2.15 | 1.93 | Trihydroxynaphthalene reductase | |
| − 0.76 | − 0.57 | 1.22 | Aldose 1-epimerase | |
| 0.54 | 0.46 | 2.07 | Flocculation protein FLO11 | |
| − 0.78 | − 1.31 | − 0.31 | Serine/threonine-protein kinase srk1 | |
| − 1.59 | − 0.49 | 0.09 | Ribosome biogenesis protein NSA2 | |
| 0.76 | 0.93 | 1.25 | Translocation protein sec66 | |
| − 0.44 | − 0.15 | − 2.64 | Putative C2H2 finger domain-containing protein | |
| 3.02 | 2.63 | 2.22 | Transport protein SEC23 | |
| 1.78 | 2.27 | − 0.11 | Aflatoxin B1 aldehyde reductase member 2 | |
| − 0.53 | − 1.18 | − 0.57 | Zinc finger protein ADR1 | |
| − 0.52 | − 0.23 | 1.10 | Nucleoporin nsp1 | |
| − 1.10 | 1.52 | − 1.52 | Peptidase S8 and S53 | |
| 3.33 | 3.51 | 3.30 | Glucoamylase | |
| − 1.45 | − 1.56 | − 0.78 | Hypothetical protein | |
| − 1.92 | − 3.24 | − 0.36 | Mitochondrial distribution and morphology protein | |
| 1.91 | 1.55 | 1.96 | Kinesin heavy chain | |
| − 1.08 | − 0.28 | − 1.07 | C2H2 type zinc finger domain-containing protein | |
| 2.50 | 2.06 | 1.34 | COP9 signalosome complex subunit 5 | |
| 0.73 | − 0.26 | 1.12 | DNA replication regulator SLD3 | |
| 1.36 | 1.63 | 1.75 | Asparagine synthase-like protein | |
| 1.48 | 0.26 | 2.53 | Protein transport protein SEC31 | |
| 2.19 | 1.61 | 1.18 | Phospho-2-dehydro-3-deoxyheptonate aldolase | |
| − 2.90 | − 1.11 | 2.29 | Glucosamine-6-phosphate deaminase | |
| 2.30 | 2.13 | 1.02 | Elongation factor 2 | |
| − 1.10 | 1.53 | 1.87 | Splicing factor 1 | |
| 0.74 | 1.08 | 0.74 | DENN domain-containing protein |
Log2 FC, the abbreviation of Log [base 2] fold change, represents the relative expression of each gene (log2 value) between the control and treatments. The letter “A” represents the controls (samples without sclerotia) and “B” represents the treatments induced by S. sclerotiorum sclerotia. The samples of two groups were collected at 8 and 24 h, respectively, and the data of gene expressions were derived from our previous research[9].
Genes interacting with Crmapk that are differentially expressed in the transcriptome of the ΔCrmapk mutant parasitising S. sclerotiorum.
| Gene ID | Log2 FC(B8/A8) | Log2 FC(B24/A24) | Annotation |
|---|---|---|---|
| 1.74 | 1.58 | NADH kinase pos5 | |
| 3.18 | 1.59 | ||
| − 1.48 | − 2.55 | Hypothetical protein | |
| − 1.38 | − 1.00 | Golgi apyrase | |
| − 1.18 | − 0.06 | Translocation protein sec66 | |
| − 4.70 | − 4.29 | Putative C2H2 finger domain-containing protein | |
| − 0.94 | − 2.57 | Peptidase S8 and S53 | |
| − 2.93 | − 3.00 | Hypothetical protein | |
| − 1.32 | − 1.84 | Mitochondrial distribution and morphology protein | |
| 0.64 | 1.03 | DNA repair protein rad14 | |
| − 1.83 | − 1.76 | Hypothetical protein |
Log2 FC, the abbreviation of Log [base 2] fold change, represents the relative expression of each gene (log2 value) between the control and treatments. The letter “A” represents the controls (samples without sclerotia) and “B” represents the treatments induced by S. sclerotiorum sclerotia. The samples of two groups were collected at 8 and 24 h, respectively, and the data of gene expressions were derived from our previous research[10].
Figure 5Expression levels of nine Crmapk-interacting genes in C. chloroleuca 67-1 under mycoparasitic conditions. The mycelia of 67-1 strain under the induction of sclerotia were collected at 8, 24 and 48 h. The letter “a” represents the controls (samples without sclerotia) and “b” represents the treatments induced by S. sclerotiorum sclerotia. Error bars indicate the standard deviation of three replicates. Statistical tests were carried out using Tukey’s test for multiple comparisons. Asterisks indicate statistically significant difference (p < 0.05).
Primers used in this study.
| No | Primer name | Sequence (5′–3′) |
|---|---|---|
| 1 | Crmapk-F | CATGGAGGCCGAATTCATGTCTCGATCAACTCAGCCCAGC |
| 2 | Crmapk-R | GCAGGTCGACGGATCCTCATCGCATGACCTCCTGGTAGAT |
| 3 | T7 | TAATACGACTCACTATAGGG |
| 4 | 3′BD | TTTTCGTTTTAAAACCTAAGAGTC |
| 5 | pGADT7-F | TAATACGACTCACTATAGGGCGAGCGCCGCCATG |
| 6 | pGADT7-R | GTGAACTTGCGGGGTTTTTCAGTATCTACGATT |
| 7 | NODE_115_3-F | AGAAGCACCCGTCACAATTG |
| 8 | NODE_115_3-R | GACACCGCTCACCATTTCAG |
| 9 | NODE_1331_7-F | ACTTTTGGCAAGTCAACCTCA |
| 10 | NODE_1331_7-R | GGTTACCAAGCCCCTCTAGG |
| 11 | NODE_201_16-F | AAGGAGAACAAGCGTCTGGA |
| 12 | NODE_201_16-R | GGGGAGGTGATCGAGACAG |
| 13 | NODE_374_8-F | GCAAAGCAGGTCCAAGATATGT |
| 14 | NODE_374_8-R | CTCGAGAAGTCCCACAGCAA |
| 15 | NODE_38_86-F | GGGACAATACTGCAGACAAGG |
| 16 | NODE_38_86-R | TGTACATGCCTTGGTAGACTGT |
| 17 | NODE_486_20-F | ATGAACATGACATGCCGAGC |
| 18 | NODE_486_20-R | GGTCTTGTCTGTGTCCTCGA |
| 19 | NODE_52_12-F | GTATTTGGACCAGTGCCGTG |
| 20 | NODE_52_12-R | CTCTTGTAGTCGGCAGGGTA |
| 21 | NODE_525_9-F | CACACAGACGGCCCCATC |
| 22 | NODE_525_9-R | GCTCGTTGTCAGCCAGTAAC |
| 23 | NODE_606_27-F | AACCGCATCAAACTTCCTGC |
| 24 | NODE_606_27-R | CCATAGCTTCTCATCGCCGG |
| 25 | EF1-F | TCGATGTCGCTCCTGACT |
| 26 | EF1-R | AGCGTGACCGTTTATTTGA |